The cyclin kinase inhibitor p21WAF1/CIP1 is required for glomerular hypertrophy in experimental diabetic nephropathy (Q73205076)
Jump to navigation
Jump to search
scientific article published on 01 November 1999
Language | Label | Description | Also known as |
---|---|---|---|
English | The cyclin kinase inhibitor p21WAF1/CIP1 is required for glomerular hypertrophy in experimental diabetic nephropathy |
scientific article published on 01 November 1999 |
Statements
The cyclin kinase inhibitor p21WAF1/CIP1 is required for glomerular hypertrophy in experimental diabetic nephropathy (English)
Al-Douahji M
Brugarolas J
Brown PA
Stehman-Breen CO
Alpers CE
1 November 1999